This result is in line with previous studies demonstrating an association between BMI and amyloid pathology in the brain and CSF in patients with sporadic AD or in apolipoprotein E (APOE) ε4 alleles carriers as well as in cognitively normal and MCI individuals, suggesting systemic changes in the earliest phases of the disease20, 31. The gene discussed is APOE; the disease is amyloidosis.